Evidence map›Paper›PMID 32154283›Full record

ArticleAnnals of translational medicine2020

Dong Wei, Fei Gao, Zhenkun Yang, Wei Wang, Yinglun Chen, Yan Lu, Jingyu Chen

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Research advances in consistency and variability inJournal of thoracic disease · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Frontiers in immunology · 2025
    Review
  7. Review
  8. Prolonged dialysis duringFrontiers in immunology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. ExtendedAnnals of translational medicine · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Dong WeiTransplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China.
Fei GaoDepartment of Emergency, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China.
Zhenkun YangJiangsu Engineering Research Center of Organ Lung Preservation, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China.
Wei WangJiangsu Engineering Research Center of Organ Lung Preservation, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China.
Yinglun ChenTransplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China.
Yan LuGuangdong Shunde Innovative Design Institute, Shunde 528311, China.
Jingyu ChenTransplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China.
China-Japan Friendship Hospital · CNGuangdong Shunde Innovative Design Institute · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEx vivo lung perfusion (EVLP) has developed as the most effective technique for estimating marginal donor lungs. This study attempted to extend the EVLP running time to 12 hours with a dialyzer rather than periodically replacing the perfusate.

methodsHuman donor lungs rejected by the clinical lung transplantation (LTx) team were obtained. After cold storage lasting 18-24 hours, lungs were randomly assigned to 2 groups: a control group and a perfusate purification (PP) group. The control group underwent EVLP in the traditional way, while a dialyzer was added into the circuit as a bypass in the PP group. The effects on lung function, microenvironment, inflammatory response, and cell death were evaluated.

resultsA total of 8 rejected donor lungs were obtained and each group was assigned to 4 cases of EVLP. Three cases were prematurely terminated because of serious lung edema and decreased lung function. There were no significant differences in airway pressure, pulmonary artery pressure, and oxygen concentration between the two groups in the first 8 hours. The pH in the control group was significantly lower than that in the PP group, and the levels of potassium and lactate were significantly higher than those in the PP group. Inflammatory markers increased in both groups, while IL-6 and IL-10 were higher in the PP group in the first 6 hours. Hematoxylin and eosin (HE) staining revealed lung injuries in both groups, but no significant difference was noted in the HE-stained slides. There were significantly more TUNEL-positive cells in the control group (69.5%±4.0%) than in the PP group (47.5%±3.9%) (P=0.000).

conclusionsUsing the modified method of EVLP reduces the high cost caused by exchanging perfusion fluid per hour and could prolong the normothermic preservation time of donor lungs.

Indexed as

dialyzerEx vivo lung perfusion (EVLP)lactatelung injury

Identifiers

PMID32154283
PMCPMC7036627
OpenAlexW2981843287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.